Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v1-EN
Language French English
Date Updated 2020-02-04 2019-10-03
Drug Identification Number 02463393 02463393
Brand name CYANOCOBALAMIN INJECTION USP CYANOCOBALAMIN INJECTION USP
Common or Proper name Cyanocobalamin Cyanocobalamin
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients VITAMIN B12 VITAMIN B12
Strength(s) 1000MCG 1000MCG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS
Packaging size 1 mL 1 mL
ATC code B03BA B03BA
ATC description VITAMIN B12 AND FOLIC ACID VITAMIN B12 AND FOLIC ACID
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-10-01 2019-10-01
Estimated end date 2020-01-31 2019-11-01
Actual end date 2020-02-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments